免疫化学分析装置:医療機器パイプライン分析2020

◆英語タイトル:Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2020

GlobalDataが発行した調査報告書(GD21MC013)◆商品コード:GD21MC013
◆発行会社(リサーチ会社):GlobalData
◆発行日:2020年11月30日
◆ページ数:278
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD12,000 ⇒換算¥1,776,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Immunochemistry Analyzers – Medical Devices Pipeline Assessment, 2020
Summary

GlobalData’s Medical Devices sector report, “Immunochemistry Analyzers – Medical Devices Pipeline Assessment, 2020″ provides comprehensive information about the Immunochemistry Analyzers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Immunochemistry analyzers are analytical laboratory equipment used to perform tests for infectious diagnostics, specific proteins, and therapeutic drugs. These analyzers are typically offered in modular increments, which can operate independently or simultaneously as a unit.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Immunochemistry Analyzers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Immunochemistry Analyzers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Immunochemistry Analyzers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

❖ レポートの目次 ❖

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Immunochemistry Analyzers Overview
3 Products under Development
3.1 Immunochemistry Analyzers – Pipeline Products by Stage of Development
3.2 Immunochemistry Analyzers – Pipeline Products by Segment
3.3 Immunochemistry Analyzers – Pipeline Products by Territory
3.4 Immunochemistry Analyzers – Pipeline Products by Regulatory Path
3.5 Immunochemistry Analyzers – Pipeline Products by Estimated Approval Date
4 Immunochemistry Analyzers – Pipeline Products under Development by Companies
4.1 Immunochemistry Analyzers Companies – Pipeline Products by Stage of Development
4.2 Immunochemistry Analyzers – Pipeline Products by Stage of Development
5 Immunochemistry Analyzers Companies and Product Overview
6 Immunochemistry Analyzers- Recent Developments
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Immunochemistry Analyzers - Pipeline Products by Stage of Development
Table 2: Immunochemistry Analyzers - Pipeline Products by Segment
Table 3: Immunochemistry Analyzers - Pipeline Products by Territory
Table 4: Immunochemistry Analyzers - Pipeline Products by Regulatory Path
Table 5: Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date
Table 6: Immunochemistry Analyzers Companies - Pipeline Products by Stage of Development
Table 7: Immunochemistry Analyzers - Pipeline Products by Stage of Development
Table 8: Abingdon Health Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Next Generation Multiplex POC Biosensor Device - Product Status
Table 10: Next Generation Multiplex POC Biosensor Device - Product Description
Table 11: Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: All-in-One Sensor - Product Status
Table 13: All-in-One Sensor - Product Description
Table 14: Acrongenomics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 15: BioLED Device - Diabetes Management - Product Status
Table 16: BioLED Device - Diabetes Management - Product Description
Table 17: ADOR Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 18: NATlab - Product Status
Table 19: NATlab - Product Description
Table 20: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview
Table 21: AgPlus Diagnostic System - Product Status
Table 22: AgPlus Diagnostic System - Product Description
Table 23: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: minDNAnalyzer - Product Status
Table 25: minDNAnalyzer - Product Description
Table 26: Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: TruDx 2000 Platform - Product Status
Table 28: TruDx 2000 Platform - Product Description
Table 29: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Clondiag HIV Molecular Device - Product Status
Table 31: Clondiag HIV Molecular Device - Product Description
Table 32: Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: BiliNow - Product Status
Table 34: BiliNow - Product Description
Table 35: PKU Now - Product Status
Table 36: PKU Now - Product Description
Table 37: ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 38: ApoStream System - Product Status
Table 39: ApoStream System - Product Description
Table 40: Aptatek BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Point Of Care Diagnostic Device - Phenylketonuria - Product Status
Table 42: Point Of Care Diagnostic Device - Phenylketonuria - Product Description
Table 43: AquaBioChip, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Gene-Z Device - Product Status
Table 45: Gene-Z Device - Product Description
Table 46: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Atolyzer Consumer Device - Product Status
Table 48: Atolyzer Consumer Device - Product Description
Table 49: Atolyzer Gene - Product Status
Table 50: Atolyzer Gene - Product Description
Table 51: Atolyzer PoC - Product Status
Table 52: Atolyzer PoC - Product Description
Table 53: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 54: UniCel DxN - Product Status

List of Figures
Figure 1: Immunochemistry Analyzers - Pipeline Products by Stage of Development
Figure 2: Immunochemistry Analyzers - Pipeline Products by Segment
Figure 3: Immunochemistry Analyzers - Pipeline Products by Territory
Figure 4: Immunochemistry Analyzers - Pipeline Products by Regulatory Path
Figure 5: Immunochemistry Analyzers - Pipeline Products by Estimated Approval Date

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 免疫化学分析装置:医療機器パイプライン分析2020(Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2020)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆